What is the current Price Target for the Anavex Life Sciences Corp. stock?

The average Anavex Life Sciences Corp. target price is $20.40. This is 757.14% higher than the current stock price. The highest price target is 782.35%, the lowest is 748.74%. 3 Analysts have issued a price target Anavex Life Sciences Corp. 2027 .

How high will the Anavex Life Sciences Corp. stock rise?

No reliable answer can be given as to how high the Anavex Life Sciences Corp. stock will rise. The performance of stocks, including the Anavex Life Sciences Corp. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Anavex Life Sciences Corp. stock today?

The performance of Anavex Life Sciences Corp. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Anavex Life Sciences Corp. stock fall?

The decline in Anavex Life Sciences Corp. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Anavex Life Sciences Corp. Forecast, price target & analysts

$2.38

1.71%

Nasdaq, Sep 25, 04:00 pm EDT. Closed.

ISIN

US0327973006

Symbol

AVXL

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Anavex Life Sciences Corp. Target price 2026 - Analyst rating & recommendation

Anavex Life Sciences Corp. Classifications & Recommendation

Buy

86%

Hold

14%

Anavex Life Sciences Corp. Price Target

Target Price	$20.40
Price	$2.38
Potential	757.14% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target Anavex Life Sciences Corp. 2027 . The average Anavex Life Sciences Corp. target price is $20.40. This is 757.14% register free of charge higher than the current stock price. The highest price target is $21.00 782.35% register free of charge , the lowest is $20.20 748.74% register free of charge .
	A rating was issued by 7 analysts: 6 Analysts recommend Anavex Life Sciences Corp. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Anavex Life Sciences Corp. stock has an average upside potential 2027 of 757.14% register free of charge . Most analysts recommend the Anavex Life Sciences Corp. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Annually

	Sep '25	2026 Estimates
Earnings Per Share $	-0.54	-0.34
	3.85%	37.04%
P/E		negative

3 Analysts have issued a Anavex Life Sciences Corp. forecast for earnings per share. The average Anavex Life Sciences Corp. EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-0.54	3.85%
2026	$-0.34 37.04% unlock
2027	$-0.56 64.71% unlock
2028	$2.32 514.29% unlock

Current	-15.60	5.11%
2026	-6.95 55.45% unlock
2027	-4.17 40.00% unlock
2028	1.01 124.22% unlock

Anavex Life Sciences Corp....

Current Anavex Life Sciences Corp. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
D. Boral Capital	Locked ➜ Locked	Locked	Mar 31 2026
D. Boral Capital	Locked ➜ Locked	Locked	Mar 26 2026
D. Boral Capital	Locked ➜ Locked	Locked	Mar 23 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Feb 10 2026
D. Boral Capital	Locked ➜ Locked	Locked	Feb 09 2026
D. Boral Capital	Locked ➜ Locked	Locked	Jan 06 2026
D. Boral Capital	Locked ➜ Locked	Locked	Dec 19 2025

Analyst Rating	Date
Locked D. Boral Capital: Locked ➜ Locked	Mar 31 2026
Locked D. Boral Capital: Locked ➜ Locked	Mar 26 2026
Locked D. Boral Capital: Locked ➜ Locked	Mar 23 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Feb 10 2026
Locked D. Boral Capital: Locked ➜ Locked	Feb 09 2026
Locked D. Boral Capital: Locked ➜ Locked	Jan 06 2026
Locked D. Boral Capital: Locked ➜ Locked	Dec 19 2025

Discover more stocks with a high price target

NIO ADR 104.57%

Alibaba Group Holding Ltd 70.15%

Rheinmetall 66.12%

Infineon 62.78%

Tencent Holdings Ltd. 56.53%

Adyen 53.79%

TUI 52.57%

Uber Technologies 47.97%

BYD 47.08%

Siemens Energy 46.63%

Adidas 42.38%

Deutsche Telekom 37.89%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now